Month: September 2025
Federal Circuit Clarifies Patent Scope and Trade Dress in Shower Curtain IP Dispute
September 30, 2025
Focus Prods. Grp. Int’l, LLC v. Kartri Sales Co(2) Authored by: Jeremy J. Gustrowsky The Federal Circuit’s September 30, 2025 decision in Focus Products Group International, LLC v. Kartri Sales Co. provides important guidance on patent claim interpretation, trademark standing,…
Read MoreUSPTO Panel Reverses §101 Rejection for AI Training Patent, Citing Real Technical Improvements
September 26, 2025
USPTO Authored by: Jeremy J. Gustrowsky A recent decision by the United States Patent and Trademark Office (USPTO) Appeals Review Panel has important implications for artificial intelligence (AI) and machine learning patents. The case involved U.S. Patent Application No. 16/319,040,…
Read MoreFederal Court Sends Back Trademark Battle Over “Aspire” in Banking and Credit Services
September 25, 2025
Apex Bank v. CC Serve Corp Authored by: Jeremy J. Gustrowsky In a recent decision, the U.S. Court of Appeals for the Federal Circuit partially upheld and partially overturned a ruling from the Trademark Trial and Appeal Board (TTAB) in…
Read MoreFederal Circuit Tosses $166 Million Patent Verdict Against AT&T and Nokia Over Faulty Expert Testimony
September 24, 2025
Finesse Wireless LLC v. AT&T Mobility LLC Authored by: Jeremy J. Gustrowsky In a major decision for patent litigation, the Federal Circuit has reversed a $166 million jury verdict against AT&T Mobility LLC and Nokia of America Corporation, finding that…
Read MoreAvoiding Intellectual Property Mistakes: The Importance of Trademarks
September 24, 2025
When it comes to branding your company or product, choosing a name that closely resembles an existing trademark can lead to some serious trouble, such as a cease and desist letter or even a trademark infringement lawsuit. To steer clear…
Read MoreFederal Circuit Rules That “Clinically Proven” Label Doesn’t Save Bayer’s Heart Drug Patent from Invalidity
September 23, 2025
Bayer Pharma Aktiengesellschaft v. Mylan Pharms. Inc Authored by: Jeremy J. Gustrowsky In a recent patent dispute over treatments for heart disease, Bayer challenged generic drug makers’ efforts to invalidate its patent on combining low-dose rivaroxaban—a blood thinner—with aspirin to…
Read MoreUnderstanding the Purpose of Trademarks
September 10, 2025
Have you ever wondered what the role of a trademark really is? Trademarks are more than just symbols or logos; they play a vital role in the marketplace by helping customers easily identify the source of a product or service.…
Read MoreDismissal With Prejudice Makes Defendant a “Prevailing Party” for Patent Attorney Fees
September 9, 2025
Future Link Sys., LLC v. Realtek Semiconductor Corp Authored by: Jeremy J. Gustrowsky In Future Link Systems, LLC v. Realtek Semiconductor Corp., the Federal Circuit clarified when a defendant can be considered a “prevailing party” entitled to attorney fees and…
Read MoreJury Verdict Overturned After “Bait-and-Switch” Trial Tactics in Marine Fuel Patent Case
September 8, 2025
Mag_m_ Tech. LLC v. Phillips 66 Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit reversed a jury verdict in favor of Phillips 66 in a patent dispute with Magēmā Technology LLC over technology for producing low-sulfur…
Read More